Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
D.Western Therapeutics Institute, Inc. | 6DW | May 16, 2024 | 0.56 | +1.83 |
Diaceutics Plc | 7DC | May 16, 2024 | 1.24 | +5.98 |
E-Therapeutics Plc | 3AQ | May 16, 2024 | 0.09 | 0.00 |
Everest Medicines Limited | 6HN | May 16, 2024 | 2.76 | 0.00 |
Evgen Pharma Plc | 8EV | May 16, 2024 | 0.00 | 0.00 |
Futura Medical | GYX | May 16, 2024 | 0.45 | +0.45 |
Galapagos NV - American Depositary Shares | GXEA | May 16, 2024 | 25.60 | +1.59 |
GeNeuro SA | GEM | May 16, 2024 | 1.49 | +6.81 |
Genoway | JEH | May 16, 2024 | 4.04 | -0.25 |
Genscript Biotech Corporation | G51 | May 16, 2024 | 1.46 | +1.39 |
GNI Group Ltd. | 3G6 | May 16, 2024 | 14.80 | -0.67 |
Healios K.K. | 6VX | May 16, 2024 | 0.83 | +0.60 |
Hemogenyx Pharmaceuticals Plc | 5HU | May 16, 2024 | 0.01 | 0.00 |
HUTCHMED (China) Limited | H7T2 | May 16, 2024 | 3.80 | -2.06 |
Hybrigenics | 3HB | May 16, 2024 | 0.00 | -4.17 |
Hyloris Pharmaceuticals SA | 52U | May 16, 2024 | 11.40 | 0.00 |
Immupharma Plc | 25I | May 16, 2024 | 0.02 | +60.71 |
Immutep Limited | YP1B | May 16, 2024 | 0.25 | +1.61 |
Inhibrx, Inc. | 1RK | May 16, 2024 | 31.40 | +0.64 |
Innovent Biologics Inc | 6IB | May 16, 2024 | 4.64 | 0.00 |
Inventiva S.A. - American Depository Shares | 6IVA | May 16, 2024 | 3.40 | -2.86 |
Ixico Plc | PYPB | May 16, 2024 | 0.08 | 0.00 |
Legend Biotech Corporation - American Depositary Shares | 9LB | May 16, 2024 | 42.20 | +0.96 |
Mabion S.A. | 272 | May 16, 2024 | 4.04 | -2.76 |
Medesis Pharma S.A. | 76D | May 16, 2024 | 1.10 | -7.56 |
Medmira Inc | 47M | May 16, 2024 | 0.06 | +5.77 |
Memphasys Limited | IG7 | May 16, 2024 | 0.00 | 0.00 |
Mesoblast Ltd | LWB | May 16, 2024 | 0.64 | +3.25 |
Nanocarrier Co Ltd | 3NQ | May 16, 2024 | 0.75 | -0.67 |
NetScientific plc | NTK1 | May 16, 2024 | 0.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.